Overview
Myocarditis caused by Candida species is a rare but serious condition characterized by inflammation of the myocardium due to fungal infection, often seen in immunocompromised individuals 1.Diagnosis
Clinical Presentation: Symptoms may include fever, chest pain, arrhythmias, and signs of heart failure 1.
Laboratory Tests: Elevated cardiac enzymes (troponin, CK-MB) and inflammatory markers (CRP, ESR) are common 1.
Imaging: Echocardiography may reveal wall motion abnormalities or pericardial effusion 1.
Histopathology: Biopsy showing fungal elements and inflammatory infiltrate is definitive 1.
Culture and PCR: Blood cultures or endomyocardial biopsy with PCR for Candida species can confirm the diagnosis 1.Management
Antifungal Therapy: First-line treatment typically involves systemic antifungal agents such as echinocandins (e.g., caspofungin) 1.
Adjunctive Treatments: Adjunctive use of corticosteroids may be considered in severe cases to reduce inflammation 1.
Supportive Care: Management of heart failure symptoms, rhythm control, and monitoring for complications 1.Special Populations
Immunocompromised Patients: Higher risk and severity; close monitoring and aggressive antifungal therapy are crucial 1.
Pregnancy: Limited data; individualized risk assessment and cautious use of antifungals are recommended 1.Key Recommendations
Confirm diagnosis through histopathological examination or positive fungal cultures/PCR 1 (Evidence: Strong).
Initiate systemic antifungal therapy with echinocandins for confirmed Candida myocarditis 1 (Evidence: Strong).
Consider corticosteroid therapy in severe cases to manage inflammation 1 (Evidence: Moderate).References
1 Srebreva L, Zlatanova J, Miloshev G, Tsanev R. Immunological evidence for the existence of H1-like histone in yeast. European journal of biochemistry 1987. link